Fever, Fever Patterns and Diseases Called €˜Fever’ €“ a Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Review of Outbreaks of Infectious Disease in Schools in England and Wales 1979-88 C
Epidemiol. Infect. (1990), 105, 419-434 419 Printed in Great Britain A review of outbreaks of infectious disease in schools in England and Wales 1979-88 C. JOSEPH1, N. NOAH2, J. WHITE1 AND T. HOSKINS3 'Public Health Laboratory Service, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ 2Kings College School o Medicine and Dentistry, Bessemer Road, London SE5 9PJ 3 Christs Hospital, Horsham, Sussex (Accepted 20 May 1990) SUMMARY In this review of 66 outbreaks of infectious disease in schools in England and Wales between 1979-88, 27 were reported from independent and 39 from maintained schools. Altogether, over 8000 children and nearly 500 adults were affected. Most of the outbreaks investigated were due to gastrointestinal infections which affected about 5000 children; respiratory infections affected a further 2000 children. Fifty-two children and seven adults were admitted to hospital and one child with measles died. Vaccination policies and use of immunoglobulin for control and prevention of outbreaks in schools have been discussed. INTRODUCTION The prevention and control of infectious disease outbreaks in schools are important not only because of the number of children at risk but also because of the potential for spread of infection into families and the wider community. Moreover, outbreaks of infection in such communities may lead to serious disruption of children's education and the curtailment of school activities. Details made available of 66 school outbreaks to the Communicable Disease Surveillance Centre between 1979 and 1988 are analysed in this paper and policies for prophylaxis, for example immunoglobulin and vaccination are described. SOURCES OF INFORMATION Information on outbreaks in schools between 1979 and 1988 was obtained from reports of investigations in which the Public Health Laboratory Service (PHLS) Communicable Disease Surveillance Centre (CDSC) had been asked to assist [1] and Communicable Disease Report (CDR) inserts (Table 1). -
Missouri Hospitalist Missouri Society
MISSOURI HOSPITALIST MISSOURI SOCIETY HOSPITALIST Publisher: Issue 22 October 22, 2009 Division of General IM University of Missouri Hospitalist Update Columbia, Missouri Dealing with Hypertensive Urgencies Syed Ahsan, MD Editor: Robert Folzenlogen MD INTRODUCTION Patients presenting with severe hypertension can often be alarming for house officers and family members. Systolic blood pressures > 180 mm Hg, with or without a diastolic blood pressure >120, have been known to progress to hypertensive emer- Inside this issue: gencies. The majority of complications are related to end organ damage; this may include encephalopa- thy, blurred vision, chest pain, unstable angina, Hospitalist Update acute myocardial infarction and acute renal insuffi- ciency, with or without proteinuria. In the absence of these acute signs, the control of hypertensive urgency remains paramount but is not considered an emergency. Case of the Month The etiology of severe, asymptomatic hypertension is extremely important in defin- ing treatment strategies. The majority of these patients have a prolonged history of uncontrolled hypertension secondary to poor compliance or inadequate treatment From the Journals regimens. Guidelines are not entirely specific in the management of hypertensive ur- gency. ID Corner TREATMENT STRATEGY Based on the current literature, the following approach is recommended: Calendar 1. Confirm that the blood pressure is elevated. The reading should be re- peated in both upper extremities; the physician should ensure that the appropriate cuff size is used and that the readings are consistent. Comments 2. Goal for blood pressure reduction: the ideal goal is to reduce the systolic blood pressure by 20-25% and this should be done over a period of hours to days. -
A Review of Undulant Fever : Particularly As to Its Incidence, Origin and Source of Infection
University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1938 A Review of undulant fever : particularly as to its incidence, origin and source of infection Richard M. Still University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Still, Richard M., "A Review of undulant fever : particularly as to its incidence, origin and source of infection" (1938). MD Theses. 706. https://digitalcommons.unmc.edu/mdtheses/706 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. ·~· A REVIEW OF UNDULANT FEVER PARTICULARLY AS TO ITS INCIDENCE, ORIGIN AND SOURCE OF INFECTION RICHARD M. STILL SENIOR THESIS PRESENTED TO THE COLLEGE OF MEDICINE, UNIVERSITY OF NEBRASKA, OMAHA, NEBRASKA, 1958 SENIOR THESIS A REVIEW OF UNDULANT FEVER PARTICULARLY AS TO ITS;. INCIDENCE, ORIGIN .AND SOURCE OF INFECTION :trJ.:RODUCTION The motive for this paper is to review the observations, on Undul:ant Fever, of the various authors, as to the comps.rat!ve im- portance of' milk borne infection and infection by direct comtaC't.•.. The answer to this question should be :of some help in the diagnos- is ot Undulant Fever and it should also be of value where - question of the disease as an occupational entity is presented. -
Adult Onset Still's Disease Accompanied by Acute Respiratory Distress Syndrome: a Case Report
EXPERIMENTAL AND THERAPEUTIC MEDICINE 12: 1817-1821, 2015 Adult onset Still's disease accompanied by acute respiratory distress syndrome: A case report XIAO-TU XI1, MAO‑JIE WANG2, RUN‑YUE HUANG2 and BANG‑HAN DING1 1Emergency Department; 2Rheumatology Department, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong 510006, P.R. China Received July 17, 2015; Accepted May 20, 2016 DOI: 10.3892/etm.2016.3512 Abstract. Adult onset Still's disease (AOSD) is a systemic vascular permeability and a loss of aerated lung tissue (8). inflammatory disorder characterized by rash, leukocytosis, ARDS occurs in 7.2‑38.9/100,000 individuals (9,10), and has fever and arthralgia/arthritis. The most common pulmo- a mortality rate of ~40% (11). Patient mortality varies based nary manifestations associated with AOSD are pulmonary on numerous factors, including age, etiology of the lung injury infiltrates and pleural effusion. The present study describes and non‑pulmonary organ dysfunction. The most common a 40‑year‑old male with AOSD who developed fever, sore risk factors for ARDS are pneumonia, sepsis, aspiration and throat and shortness of breath. Difficulty breathing promptly trauma (11). Multiple predisposing risk factors, in addition to developed, and the patient was diagnosed with acute respira- some secondary factors such as alcohol abuse and obesity, also tory distress syndrome (ARDS). The patient did not respond increase the risk (4). In addition to patient support provided by to antibiotics, including imipenem, vancomycin, fluconazole, improving oxygen delivery to the tissues and preventing multi- moxifloxacin, penicillin, doxycycline and meropenem, but was organ system failure, early recognition and correction of the sensitive to glucocorticoid treatment, including methylpred- underlying cause is important in ARDS treatment. -
Malaria History
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site. Copyright 2006, The Johns Hopkins University and David Sullivan. All rights reserved. Use of these materials permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for obtaining permissions for use from third parties as needed. Malariology Overview History, Lifecycle, Epidemiology, Pathology, and Control David Sullivan, MD Malaria History • 2700 BCE: The Nei Ching (Chinese Canon of Medicine) discussed malaria symptoms and the relationship between fevers and enlarged spleens. • 1550 BCE: The Ebers Papyrus mentions fevers, rigors, splenomegaly, and oil from Balantines tree as mosquito repellent. • 6th century BCE: Cuneiform tablets mention deadly malaria-like fevers affecting Mesopotamia. • Hippocrates from studies in Egypt was first to make connection between nearness of stagnant bodies of water and occurrence of fevers in local population. • Romans also associated marshes with fever and pioneered efforts to drain swamps. • Italian: “aria cattiva” = bad air; “mal aria” = bad air. • French: “paludisme” = rooted in swamp. Cure Before Etiology: Mid 17th Century - Three Theories • PC Garnham relates that following: An earthquake caused destruction in Loxa in which many cinchona trees collapsed and fell into small lake or pond and water became very bitter as to be almost undrinkable. Yet an Indian so thirsty with a violent fever quenched his thirst with this cinchona bark contaminated water and was better in a day or two. -
A Systematic Review and Meta-Analysis on Chloroquine And
www.nature.com/scientificreports OPEN A systematic review and meta‑analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID‑19 treatment Ramy Mohamed Ghazy1, Abdallah Almaghraby2*, Ramy Shaaban3, Ahmed Kamal4, Hatem Beshir5,6, Amr Moursi7, Ahmed Ramadan8 & Sarah Hamed N. Taha9 Many recent studies have investigated the role of either Chloroquine (CQ) or Hydroxychloroquine (HCQ) alone or in combination with azithromycin (AZM) in the management of the emerging coronavirus. This systematic review and meta‑analysis of either published or preprint observational studies or randomized control trials (RCT) aimed to assess mortality rate, duration of hospital stay, need for mechanical ventilation (MV), virologic cure rate (VQR), time to a negative viral polymerase chain reaction (PCR), radiological progression, experiencing drug side efects, and clinical worsening. A search of the online database through June 2020 was performed and examined the reference lists of pertinent articles for in‑vivo studies only. Pooled relative risks (RRs), standard mean diferences of 95% confdence intervals (CIs) were calculated with the random‑efects model. Mortality was not diferent between the standard care (SC) and HCQ groups (RR = 0.99, 95% CI 0.61–1.59, I2 = 82%), meta‑regression analysis proved that mortality was signifcantly diferent across the studies from diferent countries. However, mortality among the HCQ + AZM was signifcantly higher than among the SC (RR = 1.8, 95% CI 1.19–2.27, I2 = 70%). The duration of hospital stay in days was shorter in the SC in comparison with the HCQ group (standard mean diference = 0.57, 95% CI 0.20–0.94, I2 = 92%), or the HCQ + AZM (standard mean diference = 0.77, 95% CI 0.46–1.08, I2 = 81). -
Patterns of Proinflammatory Cytokines and Inhibitors During Typhoid Fever
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library 1306 Patterns of Proinflammatory Cytokines and Inhibitors during Typhoid Fever Monique Keuter, Edi Dharmana, M. Hussein Gasem, University Hospital, Nijmegen. Netherlands; Diponegoro University, Johanna van der Ven-Jongekrijg, Semarang. Indonesia; F. Hoffman-Lakoche, Basel, Switzerland Robert Djokomoeljanto, Wil M. V. Dolmans, Pierre Demacker, Robert Sauerwein, Harald Gallati, and Jos W. M. van der Meer Cytokines and inhibitors in plasma were measured in 44 patients with typhoid fever. Ex vivo production of the cytokines was analyzed in a whole blood culture system with and without lipopolysaccharide (LPS). Acute phase circulating concentrations of cytokines (±SD) were as follows: interleukin (IL)-IP, <140 pg/ml.; tumor necrosis factor-a (TNFa), 130 ± 50 pg/mL; IL-6, 96 ± 131 pg/ml.; and IL-8, 278 ± 293 pg/ml., Circulating inhibitors were elevated in the acute phase: IL-l receptor antagonist (IL-IRA) was 2304 ± 1427 pg/ml, and soluble TNF receptors 55 and 75 were 4973 ± 2644 pgJmL and 22,865 ± 15,143 pgJmL, respectively. LPS stimulated production of cytokines was lower during the acute phase than during convalescence (mean values: IL-IP, 2547 vs. 6576 pg/ml.; TNFa, 2609 vs. 6338 pg/rnl.; IL-6, 2416 vs. 7713 pg/ml.), LPS-stimulated production orIL-iRA was higher in the acute than during the convales cent phase (5608 vs. 3977 pg/mL). Inhibited production of cytokines during the acute phase may bedue to a switch from a proinflammatory to an antiinflammatory mode. Typhoid fever is caused by the facultative intracellular tibodies to this cytokine are detrimental [11-16], In experi gram-negative bacillus Salmonella typhi and occasionally by mental Salmonella typhimurium infection in mice. -
Communicable Disease Toolkit Liberia
WHO/CDS/2004.24 COMMUNICABLE DISEASE TOOLKIT LIBERIA 1. COMMUNICABLE DISEASE PROFILE World Health Organization 2004 Communicable Disease Working Group on Emergencies, WHO/HQ The WHO Regional Office for Africa (AFRO) WHO Office, Liberia © World Health Organization 2004 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. Further information is available at: CDS Information Resource Centre, World Health Organization, 1211 Geneva 27, Switzerland; fax: (+41) 22 791 4285, e-mail: [email protected] Communicable Disease Toolkit for LIBERIA 2004: Communicable Disease Profile. ACKNOWLEDGMENTS Edited by Dr Michelle Gayer, Dr Katja Schemionek, Dr Monica Guardo, and Dr Máire Connolly of the Programme on Communicable Diseases in Complex Emergencies, WHO/CDS. This Profile is a collaboration between the Communicable Disease Working Group on Emergencies (CD-WGE) at WHO/HQ, the Division of Communicable Disease Prevention and Control (DCD) at WHO/AFRO and the Office of the WHO Representative for Liberia. -
Medical Management of Biological Casualties Handbook
USAMRIID’s MEDICAL MANAGEMENT OF BIOLOGICAL CASUALTIES HANDBOOK Sixth Edition April 2005 U.S. ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES FORT DETRICK FREDERICK, MARYLAND Emergency Response Numbers National Response Center: 1-800-424-8802 or (for chem/bio hazards & terrorist events) 1-202-267-2675 National Domestic Preparedness Office: 1-202-324-9025 (for civilian use) Domestic Preparedness Chem/Bio Helpline: 1-410-436-4484 or (Edgewood Ops Center – for military use) DSN 584-4484 USAMRIID’s Emergency Response Line: 1-888-872-7443 CDC'S Emergency Response Line: 1-770-488-7100 Handbook Download Site An Adobe Acrobat Reader (pdf file) version of this handbook can be downloaded from the internet at the following url: http://www.usamriid.army.mil USAMRIID’s MEDICAL MANAGEMENT OF BIOLOGICAL CASUALTIES HANDBOOK Sixth Edition April 2005 Lead Editor Lt Col Jon B. Woods, MC, USAF Contributing Editors CAPT Robert G. Darling, MC, USN LTC Zygmunt F. Dembek, MS, USAR Lt Col Bridget K. Carr, MSC, USAF COL Ted J. Cieslak, MC, USA LCDR James V. Lawler, MC, USN MAJ Anthony C. Littrell, MC, USA LTC Mark G. Kortepeter, MC, USA LTC Nelson W. Rebert, MS, USA LTC Scott A. Stanek, MC, USA COL James W. Martin, MC, USA Comments and suggestions are appreciated and should be addressed to: Operational Medicine Department Attn: MCMR-UIM-O U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Fort Detrick, Maryland 21702-5011 PREFACE TO THE SIXTH EDITION The Medical Management of Biological Casualties Handbook, which has become affectionately known as the "Blue Book," has been enormously successful - far beyond our expectations. -
How I Manage the Febrile Returning Traveller*
Proc. R. Coll. Physicians Edinb. 1998; 28: 24-33 HOW I MANAGE THE FEBRILE RETURNING TRAVELLER* D. Nathwani,† Dundee Teaching Hospitals NHS Trust, DD3 8EA Humanity has but three great enemies: fever, famine and war; of these by far the greatest, by far the most terrible, is fever. Sir William Osler Throughout the centuries, the clinical diagnosis has been made or strongly suggested by the history, the presence of helpful physical findings and the observation of the patient. Like Osler, physicians since antiquity have viewed fever, an important clinical finding, as an entity worthy of unremitting attention. An eighteenth century English diarist (Fanny Gurney, Celia Book IV, 1782) wrote that ‘travelling is the ruin of all happiness’. Fortunately, this rather gloomy outlook is no longer widely held, as illustrated by the massive increase in public spending on travel and escalation in air travel by UK residents. Between 1991 and 1995 there was a rise to 22.9 million UK residents travelling abroad (International Passenger Survey, Office for National Statistics) and a 12.5 million rise in visitors to the UK over a similar period. Although Spain and France remain the most popular destinations, increasing numbers of British people (approximately three million in 1996) are travelling to the tropics and subtropics. Fever is an important and common presentation of tropical disease and sometimes may be the only manifestation of serious illness. Indeed, 81% of travellers complaining of fever admitted to the Hospital for Tropical Diseases in London, in a period of six months had travelled to the tropics or subtropics (60% sub-Saharan Africa; 13% Indian sub-continent 8% South-East Asia).1 This suggests that both primary and secondary care physicians need to be familiar with the management of patients arriving at, or returning to, this country with a febrile illness. -
Dengue and Yellow Fever
GBL42 11/27/03 4:02 PM Page 262 CHAPTER 42 Dengue and Yellow Fever Dengue, 262 Yellow fever, 265 Further reading, 266 While the most important viral haemorrhagic tor (Aedes aegypti) as well as reinfestation of this fevers numerically (dengue and yellow fever) are insect into Central and South America (it was transmitted exclusively by arthropods, other largely eradicated in the 1960s). Other factors arboviral haemorrhagic fevers (Crimean– include intercontinental transport of car tyres Congo and Rift Valley fevers) can also be trans- containing Aedes albopictus eggs, overcrowding mitted directly by body fluids. A third group of of refugee and urban populations and increasing haemorrhagic fever viruses (Lassa, Ebola, Mar- human travel. In hyperendemic areas of Asia, burg) are only transmitted directly, and are not disease is seen mainly in children. transmitted by arthropods at all. The directly Aedes mosquitoes are ‘peri-domestic’: they transmissible viral haemorrhagic fevers are dis- breed in collections of fresh water around the cussed in Chapter 41. house (e.g. water storage jars).They feed on hu- mans (anthrophilic), mainly by day, and feed re- peatedly on different hosts (enhancing their role Dengue as vectors). Dengue virus is numerically the most important Clinical features arbovirus infecting humans, with an estimated Dengue virus may cause a non-specific febrile 100 million cases per year and 2.5 billion people illness or asymptomatic infection, especially in at risk.There are four serotypes of dengue virus, young children. However, there are two main transmitted by Aedes mosquitoes, and it is un- clinical dengue syndromes: dengue fever (DF) usual among arboviruses in that humans are the and dengue haemorrhagic fever (DHF). -
Rat Bite Fever Due to Streptobacillus Moniliformis a CASE TREATED by PENICILLIN by F
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Rat Bite Fever Due to Streptobacillus Moniliformis A CASE TREATED BY PENICILLIN By F. F. KANE, M.D., M.R.C.P.I., D.P.H. Medical Superintendent, Purdysburn Fever Hospital, Belfast IT is unlikely that rat-bite fever will rver become a public health problem in this country, so the justification for publishing the following case lies rather in its rarity, its interesting course and investigation, and in the response to Penicillin. PRESENT CASE. The patient, D. G., born on 1st January, 1929, is the second child in a family of three sons and one daughter of well-to-do parents. There is nothing of import- ance in the family history or the previous history of the boy. Before his present illness he was in good health, was about 5 feet 9j inches in height, and weighed, in his clothes, about 101 stone. The family are city dwellers. On the afternoon of 18th March, 1944, whilst hiking in a party along a country lane about fifteen miles from Belfast city centre, he was bitten over the terminal phalanx of his right index finger by a rat, which held on until pulled off and killed. The rat was described as looking old and sickly. The wound bled slightly at the time, but with ordinary domestic dressings it healed within a few days. Without missing a day from school and feeling normally well in the interval, the boy became sharply ill at lunch-time on 31st March, i.e., thirteen days after the bite.